Industry: Healthcare
Published Date: January-2025
Format: PPT*, PDF, EXCEL
Delivery Timelines: Contact Sales
Number of Pages: 186
Report ID: PMRREP33130
The chromatography systems market is estimated to reach a valuation of US$ 2774.9 Mn in 2032 from a value of US$ 1627.3 Mn recorded in 2025 capturing a CAGR of 7.3% during the forecast period from 2025 to 2032.
Key Highlights of the Market
|
North America sustains a significant position in 2024 and is estimated to hold a substantial 40.5% market share in 2025. This dominance is driven by strong demand from the biopharmaceutical and healthcare sectors, particularly for drug development, quality control, and clinical diagnostics.
The region’s advanced research infrastructure, coupled with high adoption of cutting-edge technologies like automation and single-use systems, fuels continued growth. Additionally, stringent regulatory standards and the increasing need for environmental and food safety testing contribute to North America's leading role in the chromatography systems market.
The liquid chromatography systems to maintain dominance in the market. This segment is projected to hold a substantial 50.8% market share, due to its precision, versatility, and broad applications across industries. Widely used in pharmaceuticals, biotechnology, and environmental testing, these systems offer unmatched accuracy in separating, identifying, and quantifying compounds.
Technological advancements, such as enhanced automation and high-throughput capabilities, further solidify their market leadership. Increasing adoption in drug development and quality control, coupled with growing demand for food safety and clinical diagnostics, drives sustained growth. Their efficiency and adaptability position liquid chromatography systems as an essential tool across multiple sectors.
The single-use chromatography systems maintain a dominant position in the market, and to account for a market share of 39.9% in 2025. This growth is fueled by increasing demand for cost-effective and flexible bioprocessing solutions.
Their disposable design reduces contamination risks, shortens turnaround times, and improves operational efficiency. Widely used in biopharmaceutical manufacturing, especially for monoclonal antibodies and vaccines, these systems support scalability, reinforcing their market leadership.
The chromatography systems market is integral to various industries, including pharmaceuticals, biotechnology, environmental testing, and food safety, owing to its critical role in separating and analyzing compounds. These systems are essential for precise identification, quantification, and purity testing of substances in complex mixtures.
The market is characterized by advancements in technology, such as automation, miniaturization, and increased sensitivity, which have improved the efficiency and accuracy of chromatography techniques.
Key trends driving the market include the growing demand for personalized medicine, which requires high-quality separation technologies for drug development and production. Additionally, the rise in environmental concerns is boosting the need for efficient chemical analysis to monitor pollution levels.
The adoption of single-use chromatography systems is another prominent trend, providing cost-effective, scalable, and contamination-free solutions in biopharmaceutical manufacturing. Automation and the increasing focus on research and development in drug discovery further contribute to the expanding scope of the chromatography systems market.
The chromatography systems market has seen significant growth across current, historical, and futuristic timelines, driven by evolving technological advancements and industry demands. Chromatography systems were primarily used in basic chemical research, but their applications have expanded considerably over the decades.
Traditional column chromatography dominated, but as industries like pharmaceuticals and biotechnology evolved, there was a surge in the need for more efficient, precise, and automated systems. This led to the introduction of high-performance liquid chromatography (HPLC) and gas chromatography (GC), revolutionizing drug development, environmental analysis, and food testing.
Currently, the market is witnessing a shift toward more sophisticated technologies, such as single-use and miniaturized chromatography systems, which offer flexibility, reduced operational costs, and faster results. Automation has enhanced productivity, and innovations like 2D chromatography are making inroads into complex compound analysis.
The market is poised for further growth, with advancements in AI, automation, and integration with digital technologies expected to drive innovation. The focus on personalized medicine, coupled with expanding applications in emerging sectors, will continue to propel the market into the next phase of development.
Increasing Automation in Laboratory Systems
The advancement of instrumentation-dependent industries in emerging nations has been made possible by portable chromatography technology. These portable chromatography systems are suitable for use outside of the laboratory. Both transportable and user-portable versions of portable chromatography devices are available.
In addition to providing a platform for introducing green analytical chemistry issues based on variations in solvent waste production and power utilization, portable instruments can serve comparable pedagogical functions to traditional instruments. For instance, PerkinElmer Inc.’s Torion® T-9 GC/MS is the smallest portable GC/MS in the world, besides being fast, reliable, and easy to use.
Several attempts are currently underway to reduce manual sampling in the production of small molecule medications and biotech-based products. This is particularly true in the case of cell culture media where manual sampling can lead to a risk of contamination.
The use of automated sampling enables enhanced throughput by addressing the drawbacks associated with manual sampling tools, such as syringes and pipettes. Hence, automation in laboratory procedures will drive demand for chromatography systems during the forecasted period.
Rising Demand in Biopharmaceutical Production
The rising demand for chromatography systems in biopharmaceutical production is largely driven by the increasing need for efficient and high-quality drug manufacturing processes. This factor remains a key driver for the chromatography systems market.
Biopharmaceuticals, such as monoclonal antibodies and therapeutic proteins, require rigorous purification steps to meet the high standards set by regulatory bodies. As the global biopharmaceutical market grows, the demand for reliable purification technologies has surged, particularly for the production of biologics and biosimilars.
By streamlining the ion chromatography process, this system offers biopharmaceutical manufacturers the ability to improve both the speed and accuracy of their quality control measures.
The expansion of personalized medicine also drives this trend, as biopharmaceutical companies require advanced chromatography systems to tailor treatments and maintain strict quality control standards. As the industry continues to innovate, the need for advanced chromatography solutions like the Thermo Scientific Inuvion system will be pivotal in supporting efficient, scalable, and reliable biopharmaceutical production.
Shortage of Trained Skilled Operators with Advanced Skills
Chromatography techniques require a high level of expertise for proper setup, operation, and troubleshooting. The complexity of modern chromatography systems, especially in biopharmaceutical production, necessitates specialized knowledge in chemistry, instrumentation, and analytical techniques.
There is a shortage of trained professionals with these advanced skills, particularly in emerging markets. This shortage can lead to inefficiencies, longer processing times, and increased operational costs.
Iimproper handling of chromatography systems can compromise the quality and purity of biopharmaceutical products, posing risks to compliance with regulatory standards. Addressing this skills gap through training and education programs is essential for optimizing system performance and ensuring market growth.
Adoption of Cloud-Based Platforms for Remote Chromatography Monitoring and Control
The adoption of cloud-based platforms for remote chromatography monitoring and control presents a significant opportunity in the chromatography systems market. These platforms allow real-time data access, enabling operators to monitor and control chromatography systems remotely, improving efficiency and reducing downtime.
By leveraging cloud technologies, biopharmaceutical companies can enhance their ability to manage multiple systems across different locations, ensuring consistent quality and compliance.
Cloud-based solutions facilitate data storage and analysis, which supports predictive maintenance and process optimization. This remote monitoring capability is particularly valuable in the growing trend of decentralized manufacturing and personalized medicine, where flexibility and real-time decision-making are crucial.
Growing Demand for Chromatography in the Cannabis and Hemp Industries
The growing demand for chromatography in the cannabis and hemp industries presents a promising opportunity in the chromatography systems market. As the legal cannabis market expands, there is a rising need for precise testing and purification of cannabinoids, terpenes, and other compounds to ensure product quality, consistency, and compliance with regulatory standards.
Chromatography systems, particularly high-performance liquid chromatography (HPLC) and gas chromatography (GC), are essential for analyzing and separating these compounds in cannabis extracts.
With increasing consumer interest in CBD and other hemp-derived products, the need for advanced chromatography solutions to refine product formulations and meet safety regulations is growing. This trend is driving investment in chromatography technologies, providing significant growth opportunities for manufacturers and service providers in the cannabis and hemp sectors.
The competitive landscape of the chromatography systems market is characterized by the presence of key players such as Thermo Fisher Scientific, Agilent Technologies, Waters Corporation, and PerkinElmer, among others. These companies focus on innovations in chromatography technologies, such as high-performance liquid chromatography (HPLC) and gas chromatography (GC), to meet growing demand across industries like pharmaceuticals, biotechnology, and environmental testing.
Strategic initiatives, including mergers, acquisitions, and partnerships, are common as companies aim to expand their product portfolios and market reach. Additionally, increasing research and development investments and advancements in automation and software integration drive competition in the market.
Recent Developments in the Global Chromatography Systems Market
|
Attributes |
Details |
|
Forecast Period |
2025 to 2032 |
|
Historical Data Available for |
2019 to 2023 |
|
Market Analysis |
US$ Billion for Value |
|
Key Regions Covered |
|
|
Key Market Segments Covered |
|
|
Key Companies Profiled |
|
|
Report Coverage |
|
|
Customization & Pricing |
Available upon request |
By Product
By Modality
By Usage
By End-use Industry
By Region
To know more about delivery timeline for this report Contact Sales
The market is estimated to be valued at US$ 1627.3 Mn in 2025.
Increasing demand for accurate analysis in pharmaceuticals, biotechnology, and environmental testing remains a key driver.
Some of the leading companies in the market are Thermo Fisher Scientific Inc., Agilent Technologies, and PerkinElmer Inc.
The market is projected to record a CAGR of 7.3 through 2032.
A prominent opportunity lies in the the integration of automation and advanced software for enhanced efficiency.
